EUVIMEDEUVIMED entdecken
Crossref

Anti‐inflammatory and antiresorptive activities of tanshinone‐IIA mitigate alveolar bone destruction in mice with experimental periodontitis

Angelica Leticia Reis Pavanelli, Sâmmea Martins Vieira, Camila Chierici Marcantonio, Gisele Faria, Sotirios Tetradis, Pedro Paulo Chaves de Souza, Joni Augusto Cirelli, Rafael Scaf de Molon iD

Journal of Periodontology · 2025

DOI: 10.1002/jper.24-0618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontology, 2025. Verfasst von Angelica Leticia Reis Pavanelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Surgery, São Paulo State University, School of Dentistry at Araraquara, Araraquara, São Paulo, Brazil. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Periodontitis, Abietanes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: FAPESP, CNPq, Goiás State Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periodontitis is a chronic inflammatory condition that leads to progressive destruction of the alveolar bone. Currently, there is a lack of effective adjuvant treatments to nonsurgical periodontal therapy offering strong antiresorptive properties. Tanshinone IIA (T‐IIA), a lipophilic compound derived from Salvia miltiorrhiza , exhibits various biological properties. This study investigates the antiresorptive activity of tanshinone as an adjuvant therapy for periodontitis.

Methods

Forty 8‐week‐old male C57BL6/J mice were randomly assigned to four experimental groups: control (C), periodontitis (P), T‐IIA, and sodium tanshinone IIA sulfonate (STS). The C group did not undergo experimental periodontitis, while the P, T‐IIA, and STS groups were induced with periodontitis by placing ligatures around the first maxillary molars bilaterally. Tanshinones (40 mg/kg) were administered daily via oral gavage immediately following ligature placement for 10 days. The P group received only the vehicle solution. Microcomputed tomography (micro‐CT) and histological, immunohistochemical, and real‐time quantitative polymerase chain reaction (RT‐qPCR) analyses were performed.

Results

T‐IIA and STS significantly reduced the infiltration of inflammatory cells in the connective tissue and increased the percentage of fibroblasts. This treatment also mitigated alveolar bone loss caused by ligature placement compared to the P group, enhancing bone mineral density and improving bone architectural parameters. The T‐IIA and STS groups effectively lowered the number of osteoclasts and significantly downregulated the production of IL‐1β, IL‐17, and MMP‐13. The mRNA level of cathepsin K was significantly reduced in the STS group compared to the P and T‐IIA groups, whereas IL‐1β, TNF‐α, and RANKL were not statistically different among groups.

Conclusion

Our findings demonstrate that T‐IIA and STS prevent periodontitis‐induced bone loss by controlling inflammation and inhibiting osteoclastogenesis. This suggests that these compounds possess dual antiresorptive and anti‐inflammatory properties, making them promising novel therapeutic agents for treating periodontitis. Plain Language Summary Periodontitis is a serious gum disease that damages the bone supporting teeth, often leading to tooth loss. While current treatments aim to clean the affected areas, they do not always prevent further bone damage. In this study, we explored whether tanshinone IIA, a natural compound from a traditional medicinal plant, could offer extra protection against bone loss. We worked with mice to mimic human gum disease by placing small threads around their teeth to cause inflammation and bone loss. The mice were divided into four groups: one received no treatment, another had untreated periodontitis, and two groups were given different forms of tanshinone IIA for 10 days. We then examined their bones, tissues, and key markers of inflammation and bone damage. Mice treated with tanshinone IIA showed less inflammation, improved bone structure, and fewer cells that break down bone. The treatments also reduced harmful proteins linked to inflammation and tissue damage. These findings suggest that tanshinone IIA helps protect the bone by reducing inflammation and preventing excessive bone breakdown. Our research highlights tanshinone IIA as a potential new therapy for periodontitis. By targeting both inflammation and bone loss, this compound could be an interesting alternative to manage experimental periodontitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alveolar Bone LossPeriodontitisAbietanesAnti-Inflammatory AgentsBone Density Conservation AgentsAnti-Inflammatory Agents, Non-SteroidalAnimalsMaleMiceMice, Inbred C57BLX-Ray MicrotomographyCathepsin KDisease Models, AnimalRandom AllocationInterleukin-1betaOsteoclastsRANK LigandTumor Necrosis Factor-alphaPhenanthrenes

Stichwörter der Autor:innen

alveolar bone losshistologyosteoclastsperiodontal diseasetanshinone IIAtanshinone IIA sodium sulfonate

Substanzen

AbietanestanshinoneAnti-Inflammatory AgentsCathepsin KInterleukin-1betatanshinone II A sodium sulfonateRANK LigandBone Density Conservation AgentsTumor Necrosis Factor-alphaAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Diagnosis and Surgery, São Paulo State University, School of Dentistry at Araraquara, Araraquara, São Paulo, Brazil.
  • Department of Restorative Dentistry, São Paulo State University, School of Dentistry at Araraquara, Araraquara, São Paulo, Brazil.
  • Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry, Los Angeles, California, USA.
  • Innovation in Biomaterials Laboratory, School of Dentistry, Federal University of Goias, Goiania, Goias, Brazil.
  • Department of Diagnosis and Surgery, São Paulo State University, School of Dentistry at Araçatuba, Araçatuba, São Paulo, Brazil.

ORCID-Profile: Rafael Scaf de Molon

Förderung

  • FAPESP
  • CNPq
  • Goiás State Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Pavanelli, A. L. R., Vieira, S. M., Marcantonio, C. C., Faria, G., Tetradis, S., de Souza, P. P. C., Cirelli, J. A., & de Molon, R. S. (2025). Anti‐inflammatory and antiresorptive activities of tanshinone‐IIA mitigate alveolar bone destruction in mice with experimental periodontitis. Journal of Periodontology. https://doi.org/10.1002/jper.24-0618

Vancouver

Pavanelli ALR, Vieira SM, Marcantonio CC, Faria G, Tetradis S, de Souza PPC, et al. Anti‐inflammatory and antiresorptive activities of tanshinone‐IIA mitigate alveolar bone destruction in mice with experimental periodontitis. Journal of Periodontology. 2025. doi:10.1002/jper.24-0618

BibTeX
@article{Pavanelli2025,
  author = {Pavanelli, Angelica Leticia Reis and Vieira, Sâmmea Martins and Marcantonio, Camila Chierici and Faria, Gisele and Tetradis, Sotirios and de Souza, Pedro Paulo Chaves and Cirelli, Joni Augusto and de Molon, Rafael Scaf},
  title = {Anti‐inflammatory and antiresorptive activities of tanshinone‐IIA mitigate alveolar bone destruction in mice with experimental periodontitis},
  journal = {Journal of Periodontology},
  year = {2025},
  doi = {10.1002/jper.24-0618}
}
Kostenlos starten →